(PRF) FTSE RAFI US 1000 - Overview
Exchange: NYSE ARCA •
Country: USA •
Currency: USD •
Type: Etf •
ISIN: US46137V6130
Etf: Stocks, Equities, Large Companies, Index Tracking
Total Rating 53
Risk 56
Buy Signal -0.64
| Risk 5d forecast | |
|---|---|
| Volatility | 14.8% |
| Relative Tail Risk | 0.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.84 |
| Alpha | 3.86 |
| Character TTM | |
|---|---|
| Beta | 0.803 |
| Beta Downside | 0.945 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.82% |
| CAGR/Max DD | 1.15 |
Description: PRF FTSE RAFI US 1000 March 04, 2026
PRF is an exchange-traded fund (ETF) that invests at least 90% of its assets in the FTSE RAFI US 1000 Index. This index tracks the performance of approximately 1,000 large U.S. companies.
The index selects companies based on four fundamental measures of size: book value plus intangibles, adjusted cash flow, adjusted sales, and dividends plus buybacks. This methodology emphasizes value-oriented characteristics, which often include mature companies with established revenue streams and consistent shareholder returns.
Further research on ValueRay can provide detailed insights into PRFs holdings and historical performance.
Headlines to watch out for
- Underlying index performance dictates ETF value
- US large-cap company fundamentals drive index returns
- Broad market sentiment impacts ETF trading
- Fund expense ratio affects investor returns
- Regulatory changes for ETFs create compliance costs
What is the price of PRF shares?
As of March 23, 2026, the stock is trading at USD 47.05 with a total of 901,246 shares traded.
Over the past week, the price has changed by -1.94%, over one month by -4.58%, over three months by -0.21% and over the past year by +16.58%.
Over the past week, the price has changed by -1.94%, over one month by -4.58%, over three months by -0.21% and over the past year by +16.58%.
Is PRF a buy, sell or hold?
FTSE RAFI US 1000 has no consensus analysts rating.
What are the forecasts/targets for the PRF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |